✦ LIBER ✦

Pharmacokinetics of Pegylated Liposomal Doxorubicin

✍ Scribed by Alberto Gabizon, Hilary Shmeeda, Yechezkel Barenholz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors affecting the pharmacokinetics o

✍ Ninh M. La-Beck; Beth A. Zamboni; Alberto Gabizon; Hilary Schmeeda; Michael Aman 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 348 KB

Interaction pharmacokinetics of pegylate

✍ Evangelos Briasoulis; Vasilis Karavasilis; Eleftheria Tzamakou; Dimitra Rammou; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 245 KB

Correlation of toxicity with pharmacokin

✍ Olga Lyass; Beatrice Uziely; Rami Ben-Yosef; Dinah Tzemach; Norman I. Heshing; M 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

An open-label study to evaluate dose and

✍ Alberto Gabizon; Rut Isacson; Ora Rosengarten; Dina Tzemach; Hilary Shmeeda; Ram 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 459 KB

Correlation of toxicity and efficacy wit

✍ Marye J. Boers-Sonderen,Carla M. L. van Herpen… 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 245 KB

Pegylated liposomal doxorubicin: Proof o

✍ David M. Vail; Michael A. Amantea; Gail T. Colbern; Francis J. Martin; Ralf A. H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 704 KB